Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.7%, driven by Divi's Laboratories declining 2.3%. In contrast, Vanta Bioscience has gained 8.3%. Over the past 12 months, the industry was up 12%. Earnings are forecast to grow by 22% annually.
Has the Indian Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 08 May 2024 | ₹1.4t | ₹168.0b | ₹18.7b | 29x | 76.9x | 8.6x |
Fri, 05 Apr 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 28.8x | 76.4x | 8.4x |
Sun, 03 Mar 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 32.1x | 72.8x | 8x |
Tue, 30 Jan 2024 | ₹1.4t | ₹166.5b | ₹18.9b | 30.2x | 71.9x | 8.1x |
Thu, 28 Dec 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 21.7x | 77.7x | 9x |
Sat, 25 Nov 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 22.6x | 77x | 8.9x |
Mon, 23 Oct 2023 | ₹1.3t | ₹156.1b | ₹19.8b | 26.2x | 66.4x | 8.4x |
Wed, 20 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 24.8x | 72x | 9.2x |
Fri, 18 Aug 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 24.2x | 70.2x | 8.9x |
Sun, 16 Jul 2023 | ₹1.4t | ₹156.5b | ₹23.0b | 31.3x | 59.7x | 8.8x |
Tue, 13 Jun 2023 | ₹1.3t | ₹157.2b | ₹23.0b | 28x | 55.9x | 8.2x |
Thu, 11 May 2023 | ₹1.3t | ₹163.0b | ₹28.6b | 34x | 44.3x | 7.8x |
Sat, 08 Apr 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 32.4x | 38.6x | 6.9x |
Mon, 06 Mar 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 31.6x | 37.5x | 6.7x |
Wed, 01 Feb 2023 | ₹1.2t | ₹166.4b | ₹34.5b | 29.4x | 34.3x | 7.1x |
Fri, 30 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 30.3x | 35.4x | 7.4x |
Sun, 27 Nov 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 29.7x | 35.3x | 7.4x |
Tue, 25 Oct 2022 | ₹1.3t | ₹164.1b | ₹36.1b | 35.6x | 35.1x | 7.7x |
Thu, 22 Sep 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 37.6x | 35.3x | 7.8x |
Sat, 20 Aug 2022 | ₹1.3t | ₹162.6b | ₹35.8b | 37.1x | 36.4x | 8x |
Mon, 18 Jul 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 33.4x | 38.7x | 8.4x |
Wed, 15 Jun 2022 | ₹1.2t | ₹158.3b | ₹34.2b | 31.6x | 36.2x | 7.8x |
Fri, 13 May 2022 | ₹1.4t | ₹150.1b | ₹30.1b | 32.9x | 47.7x | 9.6x |
Sun, 10 Apr 2022 | ₹1.6t | ₹148.3b | ₹29.4b | 39.4x | 53x | 10.5x |
Tue, 08 Mar 2022 | ₹1.4t | ₹148.3b | ₹29.4b | 33.4x | 47.4x | 9.4x |
Thu, 03 Feb 2022 | ₹1.5t | ₹138.5b | ₹24.6b | 39.1x | 59.8x | 10.6x |
Sat, 01 Jan 2022 | ₹1.6t | ₹137.8b | ₹24.6b | 34.1x | 65.1x | 11.6x |
Mon, 29 Nov 2021 | ₹1.7t | ₹137.6b | ₹24.4b | 31.7x | 68.3x | 12.1x |
Wed, 27 Oct 2021 | ₹1.6t | ₹132.2b | ₹22.8b | 21.3x | 72.1x | 12.4x |
Fri, 24 Sep 2021 | ₹1.7t | ₹131.1b | ₹22.9b | 24.1x | 75.2x | 13.2x |
Sun, 22 Aug 2021 | ₹1.6t | ₹131.4b | ₹22.9b | 23.3x | 69.8x | 12.2x |
Fri, 09 Jul 2021 | ₹1.5t | ₹127.1b | ₹22.6b | 36.9x | 65.2x | 11.6x |
65.8x
How does Indian Clinical Research and Equipment compare with similar industries?
IN Market | -1.98% | |
Healthcare | -1.06% | |
Life Sciences | -2.68% | |
Clinical Research and Equipment | -2.68% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
540729 Vanta Bioscience | ₹75.20 | 8.3% +₹36.3m | 32.0% | PS4.6x | |
526853 Bilcare | ₹64.74 | 0.5% +₹8.2m | 45.1% | PE6.4x |